BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 24064535)

  • 1. Incidence, predictive factors and haemodynamic consequences of acute stent recoil following transcatheter aortic valve implantation with a balloon-expandable valve.
    Nombela-Franco L; Ribeiro HB; Urena M; Pasian S; Allende R; Doyle D; Delarochellière R; Delarochellière H; Laflamme L; Laflamme J; Jerez-Valero M; Côté M; Pibarot P; Larose E; Dumont E; Rodés-Cabau J
    EuroIntervention; 2014; 9(12):1398-406. PubMed ID: 24064535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of post-implant SAPIEN XT geometry and position on conduction disturbances, hemodynamic performance, and paravalvular regurgitation.
    Binder RK; Webb JG; Toggweiler S; Freeman M; Barbanti M; Willson AB; Alhassan D; Hague CJ; Wood DA; Leipsic J
    JACC Cardiovasc Interv; 2013 May; 6(5):462-8. PubMed ID: 23702010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Strategy of Underexpansion and Ad Hoc Post-Dilation of Balloon-Expandable Transcatheter Aortic Valves in Patients at Risk of Annular Injury: Favorable Mid-Term Outcomes.
    Tan JS; Leipsic J; Perlman G; Stub D; Dvir D; Hansson NC; Norgaard BL; Blanke P; Cheung A; Ye J; Thompson CR; Moss RR; Lauck S; Wood D; Webb J
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1727-32. PubMed ID: 26476612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prosthesis-Specific Predictors of Paravalvular Regurgitation after Transcatheter Aortic Valve Replacement: Impact of Calcification and Sizing on Balloon-Expandable versus Self-Expandable Transcatheter Heart Valves.
    Stähli BE; Nguyen-Kim TD; Gebhard C; Erhart L; Frauenfelder T; Tanner FC; Falk V; Landmesser U; Nietlispach F; Lüscher TF; Maier W; Binder RK
    J Heart Valve Dis; 2015 Jan; 24(1):10-21. PubMed ID: 26182615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Echocardiographic outcomes of self-expandable CoreValve versus balloon-expandable Edwards SAPIEN XT valves: the comparison of two bioprosthesis implanted in a single centre.
    Kaya D; Tanriverdi Z; Dursun H; Colluoglu T
    Int J Cardiovasc Imaging; 2016 Sep; 32(9):1371-1378. PubMed ID: 27278270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Balloon-expandable prostheses for transcatheter aortic valve replacement.
    Ribeiro HB; Urena M; Allende R; Amat-Santos IJ; Rodés-Cabau J
    Prog Cardiovasc Dis; 2014; 56(6):583-95. PubMed ID: 24838134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and severity of paravalvular aortic regurgitation with multidetector computed tomography nominal area oversizing or undersizing after transcatheter heart valve replacement with the Sapien 3: a comparison with the Sapien XT.
    Yang TH; Webb JG; Blanke P; Dvir D; Hansson NC; Nørgaard BL; Thompson CR; Thomas M; Wendler O; Vahanian A; Himbert D; Kodali SK; Hahn RT; Thourani VH; Schymik G; Precious B; Berger A; Wood DA; Pibarot P; Rodés-Cabau J; Jaber WA; Leon MB; Walther T; Leipsic J
    JACC Cardiovasc Interv; 2015 Mar; 8(3):462-471. PubMed ID: 25790764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of acute elastic recoil between the SAPIEN-XT and SAPIEN valves in transfemoral-transcatheter aortic valve replacement.
    Garg A; Parashar A; Agarwal S; Aksoy O; Hammadah M; Poddar KL; Puri R; Svensson LG; Krishnaswamy A; Tuzcu EM; Kapadia SR
    Catheter Cardiovasc Interv; 2015 Feb; 85(3):490-6. PubMed ID: 25367712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Device success and 30-day clinical outcome in patients undergoing preimplant valvuloplasty in transfemoral versus omitting valvuloplasty in transapical transcatheter aortic valve replacement.
    Wong SC; Pawar S; Minutello RM; Horn EM; Skubas NJ; Devereux RB; Salemi A
    J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1111-7. PubMed ID: 26277463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of balloon expandable transcatheter valves for valve-in-valve implantation in patients with degenerative stentless aortic bioprostheses: Technical considerations and results.
    Bapat V; Davies W; Attia R; Hancock J; Bolter K; Young C; Redwood S; Thomas M
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):917-22; discussion 922-4. PubMed ID: 25037622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation and characterization of transcatheter aortic valve effective orifice area measured by Doppler echocardiography.
    Clavel MA; Rodés-Cabau J; Dumont É; Bagur R; Bergeron S; De Larochellière R; Doyle D; Larose E; Dumesnil JG; Pibarot P
    JACC Cardiovasc Imaging; 2011 Oct; 4(10):1053-62. PubMed ID: 21999863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility and safety of transfemoral implantation of Edwards SAPIEN XT prosthesis without balloon valvuloplasty in severe stenosis of native aortic valve.
    García E; Martín P; Hernández R; Rodríguez V; Fernández A; Gama V; Almería C; Macaya C
    Catheter Cardiovasc Interv; 2014 Apr; 83(5):791-5. PubMed ID: 24285561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparatory balloon aortic valvuloplasty during transcatheter aortic valve implantation for improved valve sizing.
    Patsalis PC; Al-Rashid F; Neumann T; Plicht B; Hildebrandt HA; Wendt D; Thielmann M; Jakob HG; Heusch G; Erbel R; Kahlert P
    JACC Cardiovasc Interv; 2013 Sep; 6(9):965-71. PubMed ID: 24050862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfemoral aortic valve implantation of Edwards SAPIEN 3 without predilatation.
    Kim WK; Praz F; Blumenstein J; Liebetrau C; Gaede L; Van Linden A; Hamm C; Walther T; Windecker S; Möllmann H
    Catheter Cardiovasc Interv; 2017 Jan; 89(1):E38-E43. PubMed ID: 26945934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct transcatheter aortic valve implantation with self-expandable bioprosthesis: feasibility and safety.
    Fiorina C; Maffeo D; Curello S; Lipartiti F; Chizzola G; D'Aloia A; Adamo M; Mastropierro R; Gavazzi E; Ciccarese C; Chiari E; Ettori F
    Cardiovasc Revasc Med; 2014 Jun; 15(4):200-3. PubMed ID: 24746865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased Risk of Cerebral Embolization After Implantation of a Balloon-Expandable Aortic Valve Without Prior Balloon Valvuloplasty.
    Bijuklic K; Haselbach T; Witt J; Krause K; Hansen L; Gehrckens R; Rieß FC; Schofer J
    JACC Cardiovasc Interv; 2015 Oct; 8(12):1608-13. PubMed ID: 26386760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet activation is less enhanced in the new balloon expandable Edwards Sapien 3 valve compared to its predecessor model (Edwards Sapien XT).
    Fateh-Moghadam S; Voesch S; Htun P; Jorbenadze R; Geisler T; Gawaz M; Bocksch W
    Thromb Haemost; 2016 Jan; 115(1):109-16. PubMed ID: 26311528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European experience with the second-generation Edwards SAPIEN XT transcatheter heart valve in patients with severe aortic stenosis: 1-year outcomes from the SOURCE XT Registry.
    Schymik G; Lefèvre T; Bartorelli AL; Rubino P; Treede H; Walther T; Baumgartner H; Windecker S; Wendler O; Urban P; Mandinov L; Thomas M; Vahanian A
    JACC Cardiovasc Interv; 2015 Apr; 8(5):657-69. PubMed ID: 25946437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical profile and outcome of patients with severe aortic stenosis at high surgical risk: single-center prospective evaluation according to treatment assignment.
    Dvir D; Sagie A; Porat E; Assali A; Shapira Y; Vaknin-Assa H; Shafir G; Bental T; Nevzorov R; Battler A; Kornowski R
    Catheter Cardiovasc Interv; 2013 Apr; 81(5):871-81. PubMed ID: 22915555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of failing biological prosthesis because of "Stent creep" with valve-in-valve transcatheter aortic valve implantation.
    Attia R; Papalexopoulou N; Hancock J; Young C; Thomas M; Bapat V
    Catheter Cardiovasc Interv; 2015 Aug; 86(2):E119-25. PubMed ID: 24550020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.